Cumulative biopharmaceutical R&D expenditure
Cumulative capital expenditure invested in biopharmaceutical research and development across member companies over a designated period.
Unit trillion USD Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Cumulative biopharmaceutical R&D expenditure
United States, 2000–2025
Every record
All records
1 record · 1 region · 2000–2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Research & Development | PhRMA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cumulative biopharmaceutical R&D expenditure. Retrieved from https://statorigin.org/indicators/cumulative-biopharmaceutical-r-d-expenditure